ETF · ARKG
Ark Genomic Rev ETF
About this page
ARKG is a fund, not a company
An ETF has no officers or directors who report trades on Form 4, and no quarterly earnings. So this page shows the funds that hold it (from their 13F reports) and any trades members of Congress reported in it.
Who owns it
316 funds report owning ARKG, up from 277
Last quarter
Who bought and who sold
Change in shares held from Jun 30 to Sep 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.
Big bets
Funds with a big share of their money in ARKG
| Fund | Of fund | Value | Change |
|---|---|---|---|
| Humankind Investments LLC | 8% | $20.9M | Same |
| Florin Court Capital LLP | 15% | $14.5M | +863% |
| Midwest Financial Partners Investments, Inc. | 4% | $11.1M | −3% |
| Gimbal Financial | 4% | $6.48M | New |
Funds that hold 150 stocks or fewer, where this stock is 3% or more of what they reported. "Of fund" is its share of the fund's 13F value.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.